Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200406046975N1Phase 3Completed
Phase 3, open-label trial of chlorhexidine (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Salivary pH, Tongue plaque pH and 1 more. Started Dec 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200406046975N1.